Annuncio pubblicitario
Italia markets open in 4 hours 34 minutes
  • Dow Jones

    38.884,26
    +31,99 (+0,08%)
     
  • Nasdaq

    16.332,56
    -16,69 (-0,10%)
     
  • Nikkei 225

    38.452,17
    -382,93 (-0,99%)
     
  • EUR/USD

    1,0743
    -0,0015 (-0,14%)
     
  • Bitcoin EUR

    58.417,96
    -941,84 (-1,59%)
     
  • CMC Crypto 200

    1.299,83
    -65,30 (-4,78%)
     
  • HANG SENG

    18.519,38
    +40,01 (+0,22%)
     
  • S&P 500

    5.187,70
    +6,96 (+0,13%)
     

Autolus Therapeutics to report third quarter 2023 financial results and host conference call on November 2, 2023

Autolus Therapeutics plc
Autolus Therapeutics plc

LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2023 financial results and operational highlights before open of US markets on Thursday, November 2, 2023.

Management will host a conference call and webcast at 9:00 am ET/1:00 pm GMT to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

ANNUNCIO PUBBLICITARIO

Contact:

Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com

Lauren Williams
Investase
+44 23 9438 7760
lauren@investase.com